ACM

Asymmetry Capital Management Portfolio holdings

AUM $188M
1-Year Est. Return 45.88%
This Quarter Est. Return
1 Year Est. Return
+45.88%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$188M
AUM Growth
+$22M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
38
New
Increased
Reduced
Closed

Top Buys

1
+$15.7M
2
+$13.5M
3
+$12.8M
4
IQV icon
IQVIA
IQV
+$12.5M
5
CNC icon
Centene
CNC
+$12.2M

Top Sells

1
+$11.5M
2
+$10.5M
3
+$10.4M
4
HOLX icon
Hologic
HOLX
+$10.3M
5
SAGE
Sage Therapeutics
SAGE
+$10.2M

Sector Composition

1 Healthcare 99.63%
2 Financials 0.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVTX icon
26
Avalo Therapeutics
AVTX
$302M
– –
-186
AZN icon
27
AstraZeneca
AZN
$281B
– –
-116,242
BAX icon
28
Baxter International
BAX
$9.81B
– –
-61,570
HOLX icon
29
Hologic
HOLX
$16.7B
– –
-138,884
IRON icon
30
Disc Medicine
IRON
$3.47B
– –
-9,469
KYMR icon
31
Kymera Therapeutics
KYMR
$4.81B
– –
-89,071
LRMR icon
32
Larimar Therapeutics
LRMR
$314M
– –
-34,943
MDT icon
33
Medtronic
MDT
$133B
– –
-83,737
PODD icon
34
Insulet
PODD
$22.1B
– –
-36,732
PTCT icon
35
PTC Therapeutics
PTCT
$6.48B
– –
-215,985
RNA icon
36
Avidity Biosciences
RNA
$10.8B
– –
-126,116
SAGE
37
DELISTED
Sage Therapeutics
SAGE
– –
-229,117
ARNA
38
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-150,001
1
2